Dive Brief: The Food and Drug Administration has granted a full approval to Gilead’s COVID-19 drug Veklury, making it the first medicine to win a standard clearance from the agency to treat the disease caused by the new coronavirus. The FDA authorized Veklury for emergency use in May, a declaration that’s only valid during a… Read More »
Many times through the years, HealthNewsReview.org has criticized the National Press Foundation in Washington, DC, for accepting drug company funding for journalism training. (See articles from June 2009, July 2009, August 2010, September 2010, October 2010, March 2014, March 2015, December 2015, November 2019. I may have missed a few, but you get the picture.) They’re doing it… Read More »
By Dr. Mercola Up to 50 million Americans struggle with acne, making it the most common skin disorder in the United States.1 When it strikes during the teen years, it can lead to feelings of self-consciousness, embarrassment and depression. Many severe acne sufferers struggle with low self-confidence, feelings of alienation and social withdrawal as a… Read More »
A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This: Ignore the CDC,” co-authored by former National Institutes of Health director Harold Varmus, was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More »
As to why, Price said the jury is still out. “Our patients were not healthier. They had the same co-morbidities as everywhere else in the country. But I think it’s because we developed a totally unbiased protocol. We based our judgment calls on who and when to give the drug based on specific threshold criteria,… Read More »